MENU
ENTA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Enanta Pharmaceuticals (ENTA) Ownership - Who owns Enanta Pharmaceuticals?

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
4 Kingsbury Avenue
Phone
+1 617 607-0800
Employees
120
Web
https://www.enanta.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
322.48M
P/E Ratio
N/A
Total Cash
163.77M
Projected Growth
N/A
Total Debt
56.54M
Revenue
69.21M
Risk (Beta)
1.39
Dividend Yield
N/A
Total Cash/Share
5.63
Total Debt/Equity
N/A
Revenue/Share
2.75 USD as % of share price
View a ticker or compare two or three
ENTA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of drugs and other pharmaceuticals products

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
4 Kingsbury Avenue
Phone
+1 617 607-0800
Employees
120
Web
https://www.enanta.com